U.S. market Closed. Opens in 11 hours 36 minutes

TIL | Instil Bio, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/A138.00KN/A
Cost of Revenue4.76M5.99M2.75MN/A20.00K
Gross Profit-4.76M-5.99M-2.75M138.00K-20.00K
Operating Expenses85.78M203.29M155.56M33.78M6.58M
Selling, General & Admin42.80M62.23M48.31M14.38M2.56M
Research & Development42.99M141.06M107.25M19.40M4.03M
Other Operating Expenses72.01M-564.00K-1.20M-4.66M-5.00K
Operating Income-90.54M-226.46M-155.56M-33.64M-6.58M
Other Expenses / Income-65.55M1.21M-1.20M-3.94M63.00K
Before Tax Income-156.09M-225.25M-156.75M-37.59M-6.52M
Income Tax ExpensesN/A-2.07M39.00K151.00K-68.00K
Net Income-156.09M-223.18M-156.79M-37.74M-6.45M
Interest Expenses5.21M1.88MN/AN/AN/A
Basic Shares Outstanding6.50M6.48M6.45M6.41M6.41M
Diluted Shares Outstanding6.50M6.48M6.45M6.41M6.41M
EBITDA-85.78M-200.20M-155.56M-34.03M-6.57M
EBITDA Margin0.00%0.00%0.00%-24,660.14%0.00%
EBIT-150.88M-223.37M-156.75M-37.59M-6.52M
EBIT Margin0.00%0.00%0.00%-27,236.96%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙